Skip to main content

Table 1 Demographic and clinical characteristics of patients (n = 382)

From: Assessing multiple sclerosis-related quality of life among Iranian patients using the MSQOL-54 tool: a cross-sectional study

Variable

N (%) or Mean ± SD

Age, years (mean ± SD)

40 ± 10.9

Gender (male)

89 (23.3%)

Marital status

 Single

154 (40.3%)

 Married

228 (59.7%)

level of education

 Undergraduate

27(7.1%)

 Diploma

102(26.7%)

 Associate degree

15(3.9%)

 Bachelor

152(39.8%)

 Master

64(16.8%)

 Professional doctoral degree

22(5.8%)

Job

 Unemployed

28 (7.3%)

 Freelance

134 (35.1%)

 Government

16 (4.2%)

 Housewife

168 (44%)

 Student

13 (3.4%)

 Retired

23 (6%)

Income

 No income

214 (56%)

 1–5 million toman/month

81 (21.2%)

 5–10 million toman/month

62 (16.2%)

  > 10 million toman/month

25 (6.5%)

Physical activity

 Low

246 (64.4%)

 Moderate

88 (23%)

 High

48 (12.6%)

Comorbidity

 Heart disease

6 (1.6%)

 Diabetes

7 (1.8%)

 Hypertension

15 (3.9%)

 Hypothyroid

20 (5.2%)

Hyperthyroid

2 (0.5%)

 Cancer

6 (1.6%)

 Stroke

1 (0.3%)

 Depression

19 (5%)

Duration of MS* disease, months

111 ± 78

MS subtype

 RRMS*

354 (92.7%)

 PMS*

28 (7.3%)

Mode of MS medication administration

 Oral

254 (66.5%)

 Injection

128 (33.5%)

Anti-depressant drugs

 Tricyclic antidepressants

1%

 Selective serotonin reuptake inhibitors

1.7%

 Serotonin-norepinephrine reuptake inhibitor

1.5%

 Atypical

0.5%

Antianxiety drugs

 anticonvulsant

2.4%

 benzodiazepines

1.3%

 Nonbenzodiazepines

0.5%

Supplements

 Yes

305 (79.8%)

 No

77 (20.2%)

 Number of daily supplements used

1 ± 1.3

 Supplement used duration, months

79.2 ± 105

  1. MS Multiple sclerosis, RRMS relapsing-remitting Multiple sclerosis, PMS Progressive multiple sclerosis